Literature DB >> 8506074

Localization of acetazolamide-resistant carbonic anhydrase III in human and rat choroid plexus by immunocytochemistry and in situ hybridisation.

A Nógrádi1, C Kelly, N D Carter.   

Abstract

Carbonic anhydrase is an essential metabolic enzyme of the central nervous system and has an important role in the production and regulation of cerebrospinal fluid. Although it has been known for over 30 years that inhibition of the enzyme with acetazolamide dramatically but not completely reduces the production of cerebrospinal fluid, the precise mechanism of the inhibitory action has been only recently revealed. In this study we present evidence that apart from carbonic anhydrase II, the catalytically highly active isozyme, carbonic anhydrase III, an acetazolamide-resistant and kinetically different isozyme could be demonstrated in the epithelial cells of the developing and mature rodent and human choroid plexuses. Both isozymes express intense immunostaining revealed with specific antisera, and by using in situ hybridisation histochemistry, carbonic anhydrase III mRNA was also observed. Since the kinetic properties and proportion of brain carbonic anhydrase III in the human choroid plexus are not revealed the function of this isozyme in choroid plexus is still to be determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506074     DOI: 10.1016/0304-3940(93)90011-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Cerebrospinal fluid and lumbar puncture: a practical review.

Authors:  Ben L C Wright; James T F Lai; Alexandra J Sinclair
Journal:  J Neurol       Date:  2012-01-26       Impact factor: 4.849

2.  Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours.

Authors:  A K Parkkila; R Herva; S Parkkila; H Rajaniemi
Journal:  Histochem J       Date:  1995-12

Review 3.  Molecular mechanisms of cerebrospinal fluid production.

Authors:  P D Brown; S L Davies; T Speake; I D Millar
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

4.  Expression of the CHOP-inducible carbonic anhydrase CAVI-b is required for BDNF-mediated protection from hypoxia.

Authors:  Tori A Matthews; Allyssa Abel; Chris Demme; Teresa Sherman; Pei-wen Pan; Marc W Halterman; Seppo Parkkila; Keith Nehrke
Journal:  Brain Res       Date:  2013-11-23       Impact factor: 3.252

Review 5.  A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease.

Authors:  Gustavo Provensi; Fabrizio Carta; Alessio Nocentini; Claudiu T Supuran; Fiorella Casamenti; M Beatrice Passani; Silvia Fossati
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

Review 6.  The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors.

Authors:  Joonas Haapasalo; Kristiina Nordfors; Hannu Haapasalo; Seppo Parkkila
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

7.  Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus.

Authors:  Dagne Barbuskaite; Eva K Oernbo; Jonathan H Wardman; Trine L Toft-Bertelsen; Eller Conti; Søren N Andreassen; Niklas J Gerkau; Christine R Rose; Nanna MacAulay
Journal:  Fluids Barriers CNS       Date:  2022-06-29

8.  Effect of acetazolamide and subsequent ventriculo-peritoneal shunting on clinical signs and ventricular volumes in dogs with internal hydrocephalus.

Authors:  Malgorzata Kolecka; Nele Ondreka; Andreas Moritz; Martin Kramer; Martin J Schmidt
Journal:  Acta Vet Scand       Date:  2015-09-04       Impact factor: 1.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.